These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12092166)

  • 21. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients.
    Valcavi R; Riganti F; Bertani A; Formisano D; Pacella CM
    Thyroid; 2010 Nov; 20(11):1253-61. PubMed ID: 20929405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
    Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition from cold to hot thyroid nodules.
    Tumino S; Fornito C; Laudani A; Iurato MP; Belfiore A
    Thyroid; 1997 Dec; 7(6):897-900. PubMed ID: 9459634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
    Wémeau JL; Cousty C; Vlaeminck V
    Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsurgical approaches to the management of thyroid nodules.
    Filetti S; Durante C; Torlontano M
    Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):384-94. PubMed ID: 16932321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up.
    Rago T; Chiovato L; Aghini-Lombardi F; Grasso L; Pinchera A; Vitti P
    J Endocrinol Invest; 2001 Nov; 24(10):770-6. PubMed ID: 11765046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules.
    Kuo SW; Hu CA; Pei D; Ni KB; Shian LR
    J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thyroxine vs iodine and thyroxine. Comparison of the TSH suppression test].
    Kahaly G; Mihaljevic V; Beyer J; Krause U
    Schweiz Med Wochenschr; 1989 Jan; 119(2):59-64. PubMed ID: 2492674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size.
    Baldini M; Gallazzi M; Orsatti A; Fossati S; Leonardi P; Cantalamessa L
    J Intern Med; 2002 May; 251(5):407-14. PubMed ID: 11982740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter.
    Răcătăianu N; Bolboacă SD; Sitar-Tăut AV; Mârza S; Moga D; Valea A; Ghervan C
    Acta Clin Belg; 2018 Oct; 73(5):317-323. PubMed ID: 29452573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural course of benign thyroid nodules in a moderately iodine-deficient area.
    Erdogan MF; Gursoy A; Erdogan G
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):767-71. PubMed ID: 17121528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroxine suppressive therapy in patients with nodular thyroid disease.
    Gharib H; Mazzaferri EL
    Ann Intern Med; 1998 Mar; 128(5):386-94. PubMed ID: 9490600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive therapy with levothyroxine for solitary thyroid nodules.
    Reverter JL; Lucas A; Salinas I; Audí L; Foz M; Sanmartí A
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):25-8. PubMed ID: 1559296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation.
    Demir T; Akinci B; Comlekci A; Karaoglu O; Ozcan MA; Yener S; Yuksel F; Secil M; Yesil S
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):446-50. PubMed ID: 19138314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
    Fast S; Bonnema SJ; Hegedüs L
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
    Celani MF; Mariani M; Mariani G
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):603-8. PubMed ID: 2284885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.
    Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Grupe P; Hegedüs L
    Arch Intern Med; 2006 Jul; 166(14):1476-82. PubMed ID: 16864757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of thyroxine and potassium iodide treatment of benign nodular thyroid lesions].
    Grineva EN; Malakhova TV; Tsoĭ UA; Smirnov BI
    Ter Arkh; 2003; 75(8):72-5. PubMed ID: 14520857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current views on diagnostic standards and treatments with L-thyroxine of single non-toxic thyroid nodules or multinodular non-toxic goiter].
    Lewiński A
    Wiad Lek; 2001; 54 Suppl 1():21-30. PubMed ID: 12182027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.